Free Trial
NASDAQ:TEM

Tempus AI Q3 2026 Earnings Report

Tempus AI logo
$83.55 +6.92 (+9.03%)
Closing price 10/5/2026 04:00 PM Eastern
Extended Trading
$84.72 +1.17 (+1.40%)
As of 09:16 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Tempus AI EPS Results

Actual EPS
N/A
Consensus EPS
-$0.07
Beat/Miss
N/A
One Year Ago EPS
N/A

Tempus AI Revenue Results

Actual Revenue
N/A
Expected Revenue
$409.42 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Tempus AI Announcement Details

Quarter
Q3 2026
Time
Before Market Opens
Conference Call Date
Tuesday, November 3, 2026
Conference Call Time
4:30PM ET

Conference Call Resources

Tempus AI Earnings Headlines

Best Artificial Intelligence Stocks Worth Watching - October 3rd
Do this before December or regret it
Porter Stansberry believes President Trump will use the December G20 Summit in Miami to unveil a radical monetary reset tied to executive order 14241 - one he says could draw a sharp dividing line between prepared investors and those left behind. The last time America reset its money - under Nixon in the 1970s - it produced an average of 1,300 new millionaires per day for over 50 years. Stansberry's new documentary names a core group of assets he believes are positioned to surge as Trump's new dollar rolls out. Watch Porter Stansberry's full briefing and get his three steps to prepare before December.tc pixel
Top Artificial Intelligence Stocks To Consider - September 28th
Best Artificial Intelligence Stocks Worth Watching - September 27th
See More Tempus AI Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Tempus AI? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Tempus AI and other key companies, straight to your email.

About Tempus AI

Tempus AI (NASDAQ:TEM) is a technology company focused on applying artificial intelligence and data analytics to precision medicine. The company develops tools intended to help physicians make more informed treatment decisions by combining clinical information, molecular data and other health-related datasets.

Tempus provides genomic testing and diagnostic services, including sequencing and other molecular tests used primarily in oncology. Its platform also offers data and software solutions designed to support clinical research, pharmaceutical development, patient identification for clinical trials and the development of personalized treatment strategies.

Founded in 2015, Tempus is headquartered in Chicago and primarily serves healthcare providers, researchers and life sciences companies. The company was co-founded by Eric Lefkofsky, who serves as its chief executive officer.

View Tempus AI Profile